Publications by authors named "Fernanda Seguro"

Claim this Profile
E
Efficacy and safety of isatuximab subcutaneous plus carfilzomib and dexamethasone in patients with relapsed/refractory multiple myeloma: results of the Phase 2 study IZALCO.
Gurdeep Parmar, Marcelo Capra, Fernanda Seguro, Vania Hungria, Meletios-Athanasios Dimopoulos

Blood Cancer J· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective real-world evaluation of t(11;14) prevalence and disease biology in multiple myeloma: MEDICI study analysis.
Andrew Spencer, Maria Gavriatopoulou, Daniel Coriu, Anna Lysén, Norma C Gutiérrez, Fernanda Seguro

Blood Adv· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Digital polymerase chain reaction enhances analysis of the cKIT D816V mutation in systemic mastocytosis patients: Clinical insights.
Alexandre Eiji Kayano, Luan Lima Marchi, Luciana Nardinelli, Evelin Alves Ramos, Eliane Aparecida Rosseto, Fernanda Salles Seguro

Hematol Transfus Cell Ther· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiac Abnormalities in Hypereosinophilic Syndromes.
Viviane Tiemi Hotta, Rafael Ruas Nastari, Gardênia da Silva Lobo Oishi, Alexandre Eiji Kayano, Juliana Alzira Gonzales Oliveira, Fernanda Salles Seguro

Arq Bras Cardiol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiple myeloma and Chagas disease: qPCR as a marker for preemptive antiparasitic therapy: a case reports series and review.
Noemia Barbosa Carvalho, Vera Lúcia Teixeira de Freitas, Fernanda Salles Seguro, Rita Cristina Bezerra, Giancarlo Fatobene

Rev Inst Med Trop Sao Paulo· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world Imatinib Mesylate Treatment in Patients with Chronic Myeloid Leukemia: The Importance of Molecular Monitoring and the Early Molecular Response.
Amanda Pifano Soares Ferreira, Fernanda Salles Seguro, Andre Ramires Neder Abdo, Fernanda Maria Santos, Felipe Vieira Rodrigues Maciel

Ann Hematol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Real‑world imatinib mesylate treatment in patients with chronic myeloid leukemia: The importance of molecular monitoring and the early molecular response.
Amanda Pifano Soares Ferreira, Fernanda Salles Seguro, Andre Ramires Neder Abdo, Fernanda Maria Santos, Felipe Vieira Rodrigues Maciel

Ann Hematol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systemic amyloidosis journey from diagnosis to outcomes: a twelve-year real-world experience of a single center in a middle-income country.
Roberta Shcolnik Szor, Fabio Fernandes, Angelina Maria Martins Lino, Leonardo Oliveira Mendonça, Fernanda Salles Seguro

Orphanet J Rare Dis· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brazilian chronic myeloid leukemia working group recommendations for discontinuation of tyrosine kinase inhibitors in chronic myeloid leukemia in clinical practice.
Carla Boquimpani, Fernanda Salles Seguro, Gustavo Henrique Romani Magalhães, Ingrid Luise Soares Pinto, Israel Bendit

Hematol Transfus Cell Ther· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnosis and treatment of systemic mastocytosis in Brazil: Recommendations of a multidisciplinary expert panel.
Elvira D Rodrigues Pereira Velloso, Geórgia A Padulla, Ana Maria Mósca de Cerqueira, Adriana Martins de Sousa, Alex Freire Sandes, Fernanda Salles Seguro

Hematol Transfus Cell Ther· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of pregnancy on the outcomes of childbearing age women with chronic myeloid leukemia.
Fernanda Maria Santos, Giovanna Ghelfond, Fernanda Salles Seguro, Andre Neder R Abdo, Thales Dalessandro

Am J Hematol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-19 in chronic myeloid leukemia patients in Latin America.
Katia B Pagnano, Evelyn Herrera Peralta, Juan Ramon Navarro, Lourdes Del Rosario David Salas, Nancy Delgado, Fernanda S Seguro

Leuk Lymphoma· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. IV: CAR-T cell therapy for multiple myeloma patients.
Angelo Maiolino, Luciano J Costa, Marcelo Pasquini, Edvan de Queiroz Crusoe, Afonso Celso Vigorito, Fernanda Salles Seguro

Hematol Transfus Cell Ther· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MR 4log and low levels of NK cells are associated with higher molecular relapse after imatinib discontinuation: Results of a prospective trial.
Fernanda S Seguro, Felipe V R Maciel, Fernanda M Santos, André N R Abdo, Thales D M Pereira

Leuk Res· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Salvage treatment for refractory or relapsed acute myeloid leukemia: a 10-year single-center experience.
Wellington Fernandes da Silva, Lidiane Inês da Rosa, Fernanda Salles Seguro, Douglas Rafaele Almeida Silveira, Israel Bendit

Clinics (Sao Paulo)· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recommendations for the management of cardiovascular risk in patients with chronic myeloid leukemia on tyrosine kinase inhibitors: risk assessment, stratification, treatment and monitoring.
Fernanda Salles Seguro, Carolina Maria Pinto Domingues Carvalho Silva, Carla Maria Boquimpani de Moura, Monika Conchon, Laura Fogliatto

Hematol Transfus Cell Ther· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk factors and incidence of thrombosis in a Brazilian cohort of patients with Philadelphia-negative myeloproliferative neoplasms.
Fernanda Salles Seguro, Larissa Lane Cardoso Teixeira, Lidiane Inês da Rosa, Wellington Fernandes da Silva, Luciana Nardinelli

J Thromb Thrombolysis· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Iron overload in a teenager with xerocytosis: the importance of nuclear magnetic resonance imaging.
Reijâne Alves de Assis, Carolina Kassab, Fernanda Salles Seguro, Fernando Ferreira Costa, Paulo Augusto Achucarro Silveira

Einstein (Sao Paulo)· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dasatinib overrides imatinib resistance mediated by the F359I residue mutation in two patients with chronic myeloid leukemia.
Mariana Serpa, Sabri S Sanabani, Pedro Enrique Dorlhiac-Llacer, Luciana Nardinelli, Patricia de Barros Ferreira, Fernanda Seguro

Acta Haematol· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and tolerability after unusually low doses of dasatinib in chronic myeloid leukemia patients intolerant to standard-dose dasatinib therapy.
Mariana Serpa, Sabri S Sanabani, Israel Bendit, Fernanda Seguro, Flávia Xavier

Clin Med Insights Oncol· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to dasatinib in a patient with concomitant chronic myeloid leukemia and chronic lymphocytic leukemia.
Mariana Serpa, Israel Bendit, Fernanda Seguro, Flavia Xavier, Marcela Cavalcante

Acta Haematol· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Images in haematology. Toxoplasma gondii in the bone marrow after pancreas-kidney transplantation.
Fernanda S Seguro, Reijane A Assis, Paulo A A Silveira, Alanna M P S Bezerra

Br J Haematol· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis